Clal Biotechnology Industries Ltd.
NYSE
Clal Biotechnology Industries Ltd.'s latest marketcap:
As of 06/05/2025, Clal Biotechnology Industries Ltd.'s market capitalization has reached $13.82 M. According to our data, Clal Biotechnology Industries Ltd. is the 38170th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 13.82 M |
| Revenue (ttm) | 2.45 M |
| Net Income (ttm) | -17,861,166.88 |
| Shares Out | 156.85 M |
| EPS (ttm) | -0.11 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | n/a |
Clal Biotechnology Industries Ltd.'s yearly market capitalization.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/05/2025 | ₪48.31 M | -11.75% |
| 12/31/2024 | ₪54.74 M | -12.09% |
| 12/31/2023 | ₪62.27 M | -36.78% |
| 12/29/2022 | ₪98.5 M | -46.87% |
| 12/30/2021 | ₪185.39 M | -41.79% |
| 12/31/2020 | ₪318.5 M |
Company Profile
Clal Biotechnology Industries Ltd. Overview
Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in investments across various stages of development, including:
- Pre-clinical and incubation
- Seed, start-up, and early venture
- Emerging growth and mid-to-late venture
- PIPEs (Private Investments in Public Equity)
- Growth capital financing
Investment Focus
The firm primarily targets companies in the following sectors:
- Life sciences
- Medical devices
- Biopharmaceutical technologies
- Biotechnology
Geographic Preference
Clal Biotechnology invests in companies based in:
- United States
- Israel
Investment Strategy
- Actively participates in portfolio companies by securing board seats.
- Invests using personal capital from its management team.
- Often serves as a lead investor and major shareholder.
Company Background
Founded in July 1998, Clal Biotechnology Industries Ltd. is headquartered in Tel Aviv, Israel. It was formerly a subsidiary of Clal Industries and Investments Ltd.
Frequently Asked Questions
-
What is Clal Biotechnology Industries Ltd.'s (TLV-CBI) current market cap?As of 06/05/2025, Clal Biotechnology Industries Ltd. (including the parent company, if applicable) has an estimated market capitalization of $13.82 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Clal Biotechnology Industries Ltd. (TLV-CBI) rank globally by market cap?Clal Biotechnology Industries Ltd. global market capitalization ranking is approximately 38170 as of 06/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.